William D. Carlson
Corporate Officer/Principal at Harvard Medical School
William D. Carlson active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Harvard Medical School | Corporate Officer/Principal | - | - |
Career history of William D. Carlson
Former positions of William D. Carlson
| Companies | Position | Start | End |
|---|---|---|---|
| ARQULE, INC. | Founder | - | - |
| Smith Kline & French BV | Corporate Officer/Principal | - | - |
Thrasos Therapeutics, Inc.
 Thrasos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Thrasos Therapeutics, Inc. operates as a clinical-stage biotherapeutics company which focuses on bringing new solutions to kidney disease patients. It develops novel approaches to protect, treat and restore kidney function for this underserved patient group. The firms products include THR-184 to prevent AKI associated with cardiac surgery, THR-204 to treat certain forms of CKD, and the THR-800 series to treat cast nephropathy, a form of AKI associated with multiple myeloma. The company was founded by William D. Carlson and Murty Bosukonda in 2003 and is headquartered in Montreal, Canada. | Director/Board Member | 2002-12-31 | 2013-05-08 |
| Founder | 2002-12-31 | - |
Training of William D. Carlson
| Yale University | Doctorate Degree |
| Harvard College | Undergraduate Degree |
Statistics
International
| United States | 5 |
| Canada | 2 |
| Netherlands | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Founder | 2 |
| Director/Board Member | 1 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
Thrasos Therapeutics, Inc.
Thrasos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Thrasos Therapeutics, Inc. operates as a clinical-stage biotherapeutics company which focuses on bringing new solutions to kidney disease patients. It develops novel approaches to protect, treat and restore kidney function for this underserved patient group. The firms products include THR-184 to prevent AKI associated with cardiac surgery, THR-204 to treat certain forms of CKD, and the THR-800 series to treat cast nephropathy, a form of AKI associated with multiple myeloma. The company was founded by William D. Carlson and Murty Bosukonda in 2003 and is headquartered in Montreal, Canada. | Health Technology |
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology ArQule, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutics to treat cancers and rare diseases. The company was founded in 1993 and is headquartered in Burlington, MA. | Health Technology |
| Smith Kline & French BV |
- Stock Market
- Insiders
- William D. Carlson
- Experience
